Guangzhou-based VectorBuilder, a genetic engineering specialist incubated by the state-owned Guangzhou Industrial Investment and Capital Operation Holding Group, has reportedly raised RMB 410 million ($56.6 million) in a Series C financing round. The funding round saw participation from investors including Guangzhou Industrial Investment and Capital Operation, Legend Capital, Yuexiu Industry Investment Fund, Wanlian Securities, and Suikai Investment.
Funding to Accelerate R&D and Industry Chain Expansion
The proceeds from the Series C financing will be used to ramp up research and development (R&D) efforts. VectorBuilder aims to form a comprehensive industry chain covering all life science and biopharma sectors. This strategic move is expected to enhance the company’s capabilities in genetic engineering and further solidify its position in the rapidly growing life science market.-Fineline Info & Tech
